Who owns Innate Pharma?

Innate Pharma is formerly owned by Sofinnova Partners, through Sofinnova Capital VI, since 2000.

When did Sofinnova Partners acquire Innate Pharma?

Sofinnova Partners acquired Innate Pharma in 2000 and exited after 6 years.

Yes. Innate Pharma was exited in 2006 via IPO.

Biotech·

France·Exited 2006·Held 6yr

Innate Pharma is a healthcare / biotech company, headquartered in France.

Entry

2000

Hold

6yr

Exit

2006

Est. EV

–

Investor

HQFrance

SectorHealthcare / Biotech

NK cell biology biotech. IPO on Euronext Paris in 2006 IPO Oct 2006 Euronext Paris (IPH).

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Capital VI

6 comparable biotech deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings